Latest News
FDA Approves Daily Rasonque Pancreatic Cancer Pill
The US Food and Drug Administration has approved Rasonque, a new daily pill that doubled survival rates in clinical trials for pancreatic cancer.
The US Food and Drug Administration has approved Rasonque, a new daily pill that doubled survival rates in clinical trials for pancreatic cancer.